Voices
Heidi Ko
Heidi Ko/LinkedIn

Heidi Ko: Empowering Patients on HER2 Biomarker Testing in Breast Cancer

Heidi Ko, Medical Director, Medical Affairs at Labcorp Drug Development, shared on LinkedIn:

“Excited to share that our article on empowering patients on HER2 biomarker testing in breast cancer has been published in print by Frontiers in Digital Health

This work reflects our commitment to ensuring patients have the knowledge and tools to make informed decisions about their care

The timing couldn’t be better with SABCS25 underway and the holidays approaching. Feeling so grateful for the collaboration with Outcomes4Me that made this possible.”

Title: Empowering patients for biomarker-informed care: digital education to bridge HER2-low knowledge gaps in metastatic breast cancer

Authors: Heidi C. Ko, Stuti Patel, Rachel E. Ellsworth, Michelle F. Green, Kyle C. Strickland, Jenessa Rossi, Ashima Dua, Maya Said, Amee Sato Dossey, Carole Cuny, Theresa Dunn, Kimberly Weaner, Maria Celeste Ramirez, Cristina Nelson, Linda Bohannon, Jonathan Klein, Marcia Eisenberg, Brian Caveney, Eric A. Severson, Shakti Ramkissoon, Rebecca A. Previs

Read the full article.

Heidi Ko

More from Heidi Ko.

Amee Sato Dossey Ashima Dua Breast Cancer Brian Caveney cancer Carole Cuny Cristina Nelson Eric A Severson Heidi C. Ko Heidi Ko Jenessa Rossi Jonathan Klein Kimberly Weaner Kyle C. Strickland Linda Bohannon Marcia Eisenberg Maria Celeste Ramirez Maya Said Michelle F. Green OncoDaily Oncology Rachel E. Ellsworth Rebecca A. Previs SABCS25 Shakti Ramkissoon Stuti Patel Theresa Dunn